Evidence map›Paper›PMID 25387952›Full record

ArticleExperimental dermatology2015

p63-dependent and independent mechanisms of nectin-1 and nectin-4 regulation in the epidermis.

Maria Rosaria Mollo, Dario Antonini, Karen Mitchell, Paola Fortugno, Antonio Costanzo, Jill Dixon, Francesco Brancati, Caterina Missero

Open access · hybridAbstract read
In one paragraph

Article in Experimental dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. A novelFrontiers in genetics · 2024
    Article
  6. Nectin-4: a Novel Therapeutic Target for Skin Cancers.Current treatment options in oncology · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. NECTIN4: A Novel Therapeutic Target for Melanoma.International journal of molecular sciences · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 2 countries.

Maria Rosaria MolloCEINGE Biotecnologie Avanzate, Napoli, Italy; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Napoli, Italy.
Dario Antonini
Karen Mitchell
Paola Fortugno
Antonio Costanzo
Jill Dixon
Francesco Brancati
Caterina Missero
Bambino Gesù Children's Hospital · ITCeinge Biotecnologie Avanzate (Italy) · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITManchester Academic Health Science Centre · GBSapienza University of Rome · ITUniversity of Chieti-Pescara · ITUniversity of Manchester · GBUniversity of Naples Federico II · IT

Funding

Telethon GGP12239
6 · The paper itself

Abstract

Nectins are immunoglobulin-like cell adhesion molecules mainly localized in adherens junctions. The transcription factor p63 is a master regulator of gene expression in stratified epithelia and controls several molecular processes. As mutations in the Pvrl1 and Pvrl4 genes encoding for nectins cause genetic disorders with phenotypes similar to p63-related syndromes, we investigated whether these proteins might be under p63 transcriptional control. Here, we show that in p63-null skin, Pvrl1 gene expression is strongly reduced, whereas Pvrl4 expression is unaffected. In human and mouse primary keratinocytes p63 depletion leads to a specific downregulation of the Pvrl1 gene. Consistent with a direct regulation, chromatin immunoprecipitation experiments (ChIP) indicate that p63 binds to two conserved intronic Pvrl1 enhancer regions. Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome is a rare autosomal dominant disorder, caused by mutations in p63 gene, mainly characterized by skin fragility. To test whether nectins may be affected in AEC syndrome, their expression was measured in keratinocytes obtained from patients with AEC or from a conditional mouse model for AEC syndrome. Pvrl1 expression was reduced in AEC keratinocytes, consistent with impaired p63 function. Surprisingly, Pvrl4 expression was similarly affected, in parallel with decreased expression of the transcription factor Irf6. Consistent with the well-characterized role of Irf6 in keratinocyte differentiation and its strong downregulation in AEC syndrome, Irf6 depletion caused reduced expression of Pvrl4 in wild-type keratinocytes. Taken together, our results indicate that Pvrl1 is a bona fide target gene of the transcription factor p63, whereas Pvrl4 regulation is linked to epidermal differentiation and is under Irf6 control.

Indexed as

AnimalsAnimals, NewbornCell Adhesion MoleculesCells, CulturedEpidermisGene Expression RegulationGene Expression Regulation, DevelopmentalGenes, ReporterHumansKeratinocytesMiceMutationNectinsPhenotypePhosphoproteinsTrans-ActivatorsCell Adhesion MoleculesNECTIN1 protein, humanNectin1 protein, mouseNECTIN4 protein, humanNectin4 protein, mouseNectinsPhosphoproteinsTP63 protein, humanTrans-ActivatorsTranscription FactorsTrp63 protein, mouseTumor Suppressor Proteinsadherens junctionsIrf6p63Pvrl1Pvrl4

Identifiers

PMID25387952
PMCPMC4329386
OpenAlexW2015411228

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.